These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US. Sheikh SR; Kattan MW; Steinmetz M; Singer ME; Udeh BL; Jehi L Neurology; 2020 Sep; 95(10):e1404-e1416. PubMed ID: 32641528 [TBL] [Abstract][Full Text] [Related]
23. Family resources moderate the relationship between seizure control and health-related quality of life in children with drug-resistant epilepsy. Phillips NL; Widjaja E; Smith ML Epilepsia; 2020 Aug; 61(8):1638-1648. PubMed ID: 32640091 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Vera-Llonch M; Brandenburg NA; Oster G Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431 [TBL] [Abstract][Full Text] [Related]
25. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system. Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931 [TBL] [Abstract][Full Text] [Related]
26. Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom. Verdian L; Yi Y Seizure; 2010 Jan; 19(1):1-11. PubMed ID: 19942457 [TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080 [TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy. Markowitz MA; Mauskopf JA; Halpern MT Neurology; 1998 Oct; 51(4):1026-33. PubMed ID: 9781524 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464 [TBL] [Abstract][Full Text] [Related]
30. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland). Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076 [TBL] [Abstract][Full Text] [Related]
31. Seizure freedom improves health-related quality of life after epilepsy surgery in children. Jain P; Smith ML; Speechley K; Ferro M; Connolly M; Ramachandrannair R; Almubarak S; Andrade A; Widjaja E; Dev Med Child Neurol; 2020 May; 62(5):600-608. PubMed ID: 31709524 [TBL] [Abstract][Full Text] [Related]
32. Impact of resective surgery for pediatric drug-resistant epilepsy on emotional functioning. Phillips NL; Widjaja E; Smith ML Epilepsy Behav; 2019 Dec; 101(Pt A):106508. PubMed ID: 31677581 [TBL] [Abstract][Full Text] [Related]
33. An Initial Cost-Effectiveness Analysis of Magnetic Resonance-Guided Laser Interstitial Thermal Therapy in Pediatric Epilepsy Surgery. Sacino M; Huang SS; Alexander H; Fayed I; Keating RF; Oluigbo CO Pediatr Neurosurg; 2020; 55(3):141-148. PubMed ID: 32829333 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis for the use of serum antiepileptic drug level monitoring in children diagnosed with structural-metabolic epilepsy. Salih MR; Bahari MB; Shafie AA; Hassali MA; Al-Lela OQ; Abd AY; Ganesan VM Epilepsy Res; 2013 Mar; 104(1-2):151-7. PubMed ID: 23103061 [TBL] [Abstract][Full Text] [Related]
35. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
36. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults. Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880 [TBL] [Abstract][Full Text] [Related]
37. Why are antiepileptic drugs continued after successful epilepsy surgery in adults? Foged MT; Stefánsdóttir A; Brændgaard M; Holm E; Pinborg LH; Sabers A Epilepsy Behav; 2019 Nov; 100(Pt A):106452. PubMed ID: 31655373 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Ademi Z; Gloy V; Glinz D; Raatz H; Van Stiphout J; Bucher HC; Schwenkglenks M Swiss Med Wkly; 2016; 146():w14382. PubMed ID: 27922167 [TBL] [Abstract][Full Text] [Related]
39. Epilepsy surgery in patients with autism. Kokoszka MA; McGoldrick PE; La Vega-Talbott M; Raynes H; Palmese CA; Wolf SM; Harden CL; Ghatan S J Neurosurg Pediatr; 2017 Feb; 19(2):196-207. PubMed ID: 27885946 [TBL] [Abstract][Full Text] [Related]